Aligos Therapeutics (ALGS) Earnings Date & Reports

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALGS is expected to report earnings to fall 47.96% to -114 cents per share on July 30

Aligos Therapeutics ALGS Stock Earnings Reports

Q2'26

Est.

$-1.15

Q1'26

Beat

by $1.08

Q4'25

Missed

by $1.66

Q3'25

Missed

by $2.79

Q2'25

Missed

by $1.29

The last earnings report on May 07 showed earnings per share of -221 cents, beating the estimate of -328 cents. With 21.55K shares outstanding, the current market capitalization sits at 35.09M.

View a ticker or compare two or three

Compare

ALGS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ALGS